GlassScriptPhysician profile
Robert G Wilkins
NPI 1598875304
$4,585.63
in general payments reported to CMS, 2019-2025
30 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,209 · 2020: $344 · 2021: $627 · 2022: $561 · 2023: $661 · 2024: $807 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,844.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $878.93 | 2019-2024 | Impella |
| Inari Medical, INC. | $652.33 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $599.13 | 2019-2025 | Ranger, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Philips North America LLC | $504.38 | 2019-2024 | (Az7) Lasers, (P84) Igt Devices Systems, (Br5) Peripheral Ivus |
| Novartis Pharmaceuticals Corporation | $276.88 | 2019-2023 | |
| Abbott Laboratories | $268.32 | 2019-2025 | Esprit, Diamondback Peripheral, Supera |
| Medtronic, INC. | $237.08 | 2021-2025 | Hawkone, Corevalve Evolut R, Symplicity G3 |
| Cardiva Medical, INC. | $200.97 | 2019 | |
| Venturemed Group, INC. | $149.86 | 2019 | |
| Edwards Lifesciences Corporation | $117.37 | 2023-2025 | Sapien 3 Ultra Resilia, Pascal |
| Chiesi USA, INC. | $98.88 | 2020-2021 | |
| Medtronic Vascular, INC. | $84.47 | 2019 | |
| Merck Sharp & Dohme LLC | $76.69 | 2021-2023 | Verquvo |
| Shockwave Medical, INC | $71.46 | 2020-2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.86 | 2022-2025 | Lifevest |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $45.10 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $42.67 | 2023-2025 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.59 | 2021-2023 | Jardiance |
| Terumo Medical Corporation | $27.59 | 2021-2023 | Angio-Seal |
| Celonova Biosciences, INC. | $27.00 | 2019 | |
| Recor Medical INC | $21.06 | 2024 | Paradise Renal Denervation System |
| Bracco Diagnostics INC. | $20.07 | 2022 | |
| Amgen INC. | $18.74 | 2022 | |
| Biosense Webster, INC. | $17.92 | 2023 | Carto 3 |
| Bayer Healthcare Pharmaceuticals INC. | $17.74 | 2025 | |
| Stryker Corporation | $16.09 | 2025 | Artix Mt |
| Pfizer INC. | $13.14 | 2021 | |
| W. L. Gore & Associates, INC. | $11.31 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wilkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.